Identification and characterization of imidazoline-binding sites from calf striatum

By Czerwiec E.   De Backer J.-P.   Flamez A.   Vauquelin G.  

European Journal of Pharmacology, Vol. 315, Iss. 1, 1996-11 ,pp. : 99-109

Elsevier

Access to resources Recommend Favorite

Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I 1 and I 2 binding sites

By Coupry I.   Armsby C.C.   Alper S.L.   Brugnara C.   Parini A.  

European Journal of Pharmacology, Vol. 295, Iss. 1, 1996-01 ,pp. : 109-112

Elsevier

Access to resources Recommend Favorite

Imidazoline binding sites in Huntington's and Parkinson's disease putamen

By Reynolds G.P.   Boulton R.M.   Pearson S.J.   Hudson A.L.   Nutt D.J.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 19-21

Elsevier

Access to resources Recommend Favorite

Imidazoline Binding Sites in the Endocrine Pancreas: Can They Fulfil Their Potential as Targets for the Development of New Insulin Secretagogues?

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1413-1431

Bentham Science Publishers

Access to resources Recommend Favorite

Imidazoline Binding Sites and Receptors in Cardiovascular Tissue - an investigation into their relationship to imidazoline, 2 and H 3 receptors

By Molderings G.J.   Gothert M.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 17-22

Elsevier

Access to resources Recommend Favorite